welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Microlin Bio to Acquire Nucleic Acid Therapeutic Assets of Marina Biotech
Microlin Bio, Inc., a development stage biotechnology company focused on the development of microRNA based therapeutics for cancer, and Marina Biotech, Inc., a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced that the companies have executed a term sheet under which Microlin intends to acquire Marina’s nucleic acid therapeutics assets.
expertly curated content related to this topic
-
Manchester Centre for Genomic MedicineThe Manchester Centre for Genomic Medici...
-
darrell henry’s sufferfestThis page is dedicated to Darrell Henry,...
-
Travis H. BrayTravis Bray is the Founder and Executive...
-
Steven GallingerHead of the Hepatobiliary and pancreatic...
-
William M. Grady, MDGastroenterology Specialist, University ...
-
the cancer documentsAs a third generation Familial Adenomato...
-
André D’Hoore, MD, PhDAndré D’Hoore graduated as MD at the ...